[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper describes EGFR mutations as drivers of cancer progression, influencing downstream signaling pathways and contributing to uncontrolled cell growth.",
        "judgment": "Yes",
        "reasoning": "The text explicitly links EGFR mutations to cancer progression, establishing a clear disease mechanism."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper uses an in vitro kinase activity assay to assess the impact of the L858R mutation on EGFR's enzymatic function.",
        "judgment": "Yes",
        "reasoning": "Kinase activity assays are standard for evaluating the impact of mutations on tyrosine kinase function, which is central to EGFR's role in cancer.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "The kinase activity assay includes wild-type EGFR as a control and results are shown for triplicate experiments.",
        "judgment": "Yes",
        "reasoning": "Both normal/wild-type (wild-type EGFR) and abnormal/positive (kinase activity without mutation) controls were used. Triplicate experiments are reported.",
        "next_step_or_outcome": "Proceed to Sub-step 3c"
      },
      {
        "step_name": "Step 3c: Variant Controls",
        "extracted_paper_info": "The paper explicitly states that the kinase activity of the L858R mutant EGFR was compared to a known pathogenic EGFR variant (data not shown).",
        "judgment": "Yes",
        "reasoning": "A known pathogenic variant was included as a positive control for comparing kinase activity, strengthening the evidence's validity.",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step_name": "Step 4a: Statistical Analyses",
        "extracted_paper_info": "The paper reports a significant increase (p < 0.001) in kinase activity for the L858R mutant compared to the wild-type EGFR.",
        "judgment": "Yes",
        "reasoning": "A p-value (p<0.001) is provided which represents a statistical analysis of the data",
        "next_step_or_outcome": "Proceed to Step 4c"
      },
      {
        "step_name": "Step 4c: Correlate OddsPath",
        "extracted_paper_info": "No OddsPath value is explicitly given, but the reported p-value and substantial increase in kinase activity strongly suggest a high pathogenicity likelihood.",
        "judgment": "N/A",
        "reasoning": "While a direct OddsPath is not provided, the substantial increase in kinase activity, combined with a significant p-value, indicates a moderately high likelihood of pathogenicity.",
        "next_step_or_outcome": "Assign PS3 Strength"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_moderate"
    },
    "overall_conclusion": "The L858R mutation demonstrates a statistically significant increase in kinase activity compared to wild-type EGFR and a known pathogenic variant, indicating a moderately high pathogenicity likelihood. The absence of a directly reported OddsPath value prevents a stronger classification, but the robust statistical findings support a PS3 moderate strength."
  }
]